Jose Ramon Arribas
Overview
Explore the profile of Jose Ramon Arribas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Gea-Grela A, Mican R, de Miguel R, Serrano L, Marcelo C, Montes M, et al.
Open Forum Infect Dis
. 2025 Mar;
12(3):ofaf087.
PMID: 40059977
Background: We previously described the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) as a switch strategy in real life in people with HIV (PWH) at 48 weeks. We did not find that...
2.
Bailon L, Molto J, Curran A, Cadinanos J, Carlos Lopez Bernaldo de Quiros J, de Los Santos I, et al.
Nat Commun
. 2025 Mar;
16(1):2146.
PMID: 40038256
Building on results from the AELIX-002 trial with HIVACAT T-cell immunogen (HTI)-based vaccines, the AELIX-003 (NCT04364035) trial tested the safety of the combination of ChAdOx1.HTI (C) and MVA.HTI (M), with...
3.
Garcia-Perez J, Borobia A, Perez-Olmeda M, Portoles A, Castano L, Campins-Arti M, et al.
iScience
. 2024 Sep;
27(9):110728.
PMID: 39286494
CombiVacS study has demonstrated a strong immune response of the heterologous ChAdOx1-S/BNT162b2 vaccine combination. The primary outcomes of the study were to assess the humoral immune response against SARS-CoV-2, 28 ...
4.
Diez-Vidal A, Mora-Rillo M, Arribas J
Enferm Infecc Microbiol Clin (Engl Ed)
. 2024 May;
42(7):394-395.
PMID: 38714418
No abstract available.
5.
Condes E, Arribas J
Enferm Infecc Microbiol Clin
. 2024 Apr;
39(5):256-257.
PMID: 38620683
No abstract available.
6.
Ramos-Ruperto L, Arcos-Rueda M, de Miguel-Buckley R, Busca-Arenzana C, Mican R, Montejano R, et al.
HIV Med
. 2024 Feb;
25(6):684-691.
PMID: 38379338
Introduction: Dolutegravir + rilpivirine (DTG + RPV) is an effective antiretroviral therapy regimen approved in clinical guidelines as a switch therapy for virologically suppressed people with HIV. Our study aimed...
7.
Montejano R, Arribas J
Clin Infect Dis
. 2024 Feb;
79(5):1323.
PMID: 38366997
No abstract available.
8.
Vasquez Manau J, Marcelo Calvo C, de Gea Grela A, Ramos Ruperto L, Serrano L, Busca Arenzana C, et al.
Enferm Infecc Microbiol Clin (Engl Ed)
. 2023 Apr;
42(3):130-134.
PMID: 37003903
Introduction: Due to hepatitis B virus (HBV) treatment and vaccination during the last decades in Spain, epidemiological and prognosis of chronic hepatitis B (CHB) may have changed. Methods: Retrospective review...
9.
de Miguel R, Rial-Crestelo D, Dominguez-Dominguez L, Montejano R, Esteban-Cantos A, Aranguren-Rivas P, et al.
EBioMedicine
. 2023 Feb;
89:104486.
PMID: 36806001
No abstract available.
10.
Butta N, Arias-Salgado E, Monzon Manzano E, Acuna P, Alvarez Roman M, Buno-Soto A, et al.
Res Pract Thromb Haemost
. 2023 Jan;
7(1):100049.
PMID: 36685004
Background: Several cases of unusual thrombotic events and thrombocytopenia were described after vaccination with recombinant adenoviral vectors encoding the spike protein antigen of SARS-CoV-2. Objectives: The objective of this study...